
Klenzaids Pharmaceutics Private Limited
Founded in 2007 and headquartered in Maharashtra, India.
Founded in 2007 and headquartered in Maharashtra, India.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
U24230MH2007PTC171877
171877
Private Limited Indian Non-Government Company
21 Jun 2007
-
-
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Monisha Narke ![]() | Director | 21-Jun-2007 | Current |
Mehernosh Engineer ![]() | Director | 21-Jun-2007 | Current |
Chandru Shahani ![]() | Director | 21-Jun-2007 | Current |
Enhance accessibility to Klenzaids Pharmaceutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Klenzaids Pharmaceutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Monisha Narke is a mutual person
Monisha Narke is a mutual person
Monisha Narke is a mutual person
Monisha Narke is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Klenzaids Pharmaceutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Klenzaids Pharmaceutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Klenzaids Pharmaceutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mehernosh Eruch Engineer was appointed as a Director was appointed as a Director on 21 Jun 2007 & has been associated with this company since 17 years 9 months .
Chandru Mangaram Shahani was appointed as a Director was appointed as a Director on 21 Jun 2007 & has been associated with this company since 17 years 9 months .
Monisha Amit Narke was appointed as a Director was appointed as a Director on 21 Jun 2007 & has been associated with this company since 17 years 9 months .
Klenzaids Pharmaceutics Private Limited was registered on 21 Jun 2007 with Roc Mumbai & aged 17 years 9 months as per MCA records.
Klenzaids Pharmaceutics Private Limited was incorporated on 21 Jun 2007.
The authorized share capital of Klenzaids Pharmaceutics Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.00.
Currently 3 directors are associated with Klenzaids Pharmaceutics Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Klenzaids Pharmaceutics Private Limited is A-21 Midc Industrial Area Street No.3 Opp. Esic Hospital Midc, Andheri (East) India, Mumbai, Maharashtra, 400093.
The corporate identification number (CIN) of Klenzaids Pharmaceutics Private Limited is U24230MH2007PTC171877 and the company number is 171877 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.